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ABSTRACT Extended laboratory culture and antimicrobial susceptibility testing timelines hinder rapid species
identification and susceptibility profiling of bacterial pathogens associated with bovine respiratory disease, the
most prevalent cause of cattle mortality in the United States. Whole-genome sequencing offers a culture-
independent alternative to current bacterial identification methods, but requires a library of bacterial reference
genomes for comparison. To contribute new bacterial genome assemblies and evaluate genetic diversity and
variation in antimicrobial resistance genotypes, whole-genome sequencing was performed on bovine respiratory
disease–associated bacterial isolates (Histophilus somni, Mycoplasma bovis, Mannheimia haemolytica,
and Pasteurella multocida) from dairy and beef cattle. One hundred genomically distinct assemblies were
added to the NCBI database, doubling the available genomic sequences for these four species. Computer-
based methods identified 11 predicted antimicrobial resistance genes in three species, with none being de-
tected inM. bovis. While computer-based analysis can identify antibiotic resistance genes within whole-genome
sequences (genotype), it may not predict the actual antimicrobial resistance observed in a living organism
(phenotype). Antimicrobial susceptibility testing on 64 H. somni, M. haemolytica, and P. multocida isolates
had an overall concordance rate between genotype and phenotypic resistance to the associated class of
antimicrobials of 72.7% (P , 0.001), showing substantial discordance. Concordance rates varied greatly among
different antimicrobial, antibiotic resistance gene, and bacterial species combinations. This suggests that antimi-
crobial susceptibility phenotypes are needed to complement genomically predicted antibiotic resistance gene
genotypes to better understand how the presence of antibiotic resistance genes within a given bacterial species
could potentially impact optimal bovine respiratory disease treatment and morbidity/mortality outcomes.
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Historically,bacterialpathogenswere identifiedbybiochemical, antigen,
or PCR-basedmethods, with results taking fromdays toweeks. Culture-
independent diagnostic testing (CIDT), typically used to identify slow-
growing agents or those that cannot be cultured in vitro (Janda and
Abbot 2014), is gaining attention due to the availability of whole-
genome sequence (WGS) data. WGS can reveal a pathogen’s identity
and uncover other clinically useful information typically garnered
through multiple diagnostic tests (Gilmour et al. 2013).
Employment of WGS for pathogen identification in Salmonella
(Mohammed and Cormican 2015), Klebsiella pneumoniae (Marsh
et al. 2015), Neisseria meningitidis (Mustapha et al. 2015), and
Escherichia coli (Berenger et al. 2015) outbreaks demonstrated the
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effectiveness of this approach, but highlighted significant limitations
due to the paucity of published pathogen genome sequences. It was
recognized that broad sampling and establishing a global genomic
database from isolates would be required to understand the genetic
diversity and distribution of traits within a pathogen population
(Mutreja et al. 2011; Koser et al. 2014).
CIDT could be useful in characterizing pathogens associated with
bovinerespiratorydisease (BRD)complex, themostprevalent andcostly
cause of mortality for cattle in the United States (Chirase and Green
2000; USDA 2011a). Several bacterial pathogens are associated with
BRD, withHistophilus somni,Mycoplasma bovis,Mannheimia haemolytica,
and Pasteurella multocida being the most common (Griffin et al. 2010).
Complete bacterial genomes are available for two strains ofH. somni, five of
M. bovis, 10 ofM. haemolytica, and 11 of P. multocida (Table 1).
It is important to consider antimicrobial resistance and the spread of
antimicrobial resistance genes (ARG) in treatment decisions associated
with common diseases such as BRD (Koser et al. 2014). Understanding
the epidemiology of antimicrobial resistance in BRD pathogens in
healthy cattle, as well as treated and untreated sick cattle, is crucial to
understanding the role of resistance in BRD treatment failure. In ad-
dition, the increasing use of WGS in antimicrobial resistance surveil-
lance necessitates a better understanding of the degree of concordance
between phenotypic susceptibility and resistance genotype.
The primary objective of this studywas toperformWGSonbacterial
isolates collected fromuntreated BRD-affected beef anddairy cattle, and
unaffected dairy cattle, to contribute additional bacterial genome se-
quences that could be used for CIDT in the future. Secondary study
objectives were to perform bioinformatic analyses and susceptibility
testing to analyze concordance between phenotypic susceptibility and
resistance genotype. Identification of distinguishing genomic charac-
teristics, such as ARG, of different strains of the major BRD pathogens
may facilitate a better understanding of these pathogens and their host
interactions with the goal of identifying improved treatment methods
specific to the host species, ARG genotype, and pathogen combination.
MATERIALS AND METHODS
Cattle sampling
Personnel at a northern California feedlot and a central California dairy
calf nursery cared for the animals used in this study. In the calf nursery,
preweaned Holstein dairy calves 22–60 d of age, who had never been
treated for BRD nor treated with antimicrobials for any reason within
the previous 10 d, were enrolled in a matched case-control study be-
tween July 2011 and January 2012, as described previously (Love et al.
2014; Neibergs et al. 2014). Upon morning observation, BRD suspect
calves and matched adjacent control calves were scored using a clinical
scoring system that assigns numerical values from 0 to 3 based on
severity of symptoms for rectal temperature, cough, nasal discharge,
ocular discharge, ear or head tilt or droop, and fecal consistency, with a
score of $5 classified as a case (McGuirk 2008). Guarded deep naso-
pharyngeal swabs were collected from cases and control calves and
placed into 1 ml of bacterial transport media (Brucella broth with
15% glycerol) for the detection of bacteria as described (Love et al.
2014). All samples were stored on wet ice in the dark until completion
of sampling and delivery to the lab for aerobic bacteria andMycoplasma
culturing (Fulton and Confer 2012). Similar procedures were followed
for beef cattle diagnosed as BRD cases on a California feedlot. Sampling
was performed in compliance with approved Institutional Animal Care
and Use protocols at the University of California, Davis (protocols
16431 and 17974).
Bacterial isolates
Aerobic cultures from dairy calves were set up on sheep blood agar and
chocolate agar plates and incubated at 37 in 7% CO2 for 2–4 d. Swabs
for Mycoplasma isolation were swished in Mycoplasma D broth and
incubated aerobically at 37 for 2–3 d, then plated to Mycoplasma N
plates and incubated at 37 in 7%CO2 for up to 7 d. Bacteria from dairy
cattle were isolated by morphology and subjected to testing for species
identification at the California Animal Health and Food Safety Labo-
ratory System Tulare laboratory. Urease detection, triple sugar iron
agar, oxidase, indole production, hemolysis on sheep blood agar, and
Gram stain testing were performed on M. haemolytica, P. multocida,
and H. somni isolates. b-Galactosidase testing was performed on
P. multocida and M. haemolytica and trehalose fermentation testing
n Table 1 Known reference sequences for the species sequenced
in this study
Strain GenBank Accession Publication
2336 GCA_000019405.1 Siddaramappa et al.
(2011)
129PT GCA_000011785.1 Challacombe et al.
(2007)
Hubei1 GCA_000219375.1 Li et al. (2011)
HB0801 GCA_000270525.1 Qi et al. (2012)
CQ-W70 GCA_000696015.1 None
NM2012 GCA_000183385.1 Wise et al. (2010)
PG45 GCA_001043135.1 None
M42548 GCA_000376645.1 Eidam et al. (2013)
89010807N_lktA GCA_000963675.1 Heaton et al. (2015)
D153 GCA_000422145.1 Hauglund et al. (2013)
D171 GCA_000427275.1 Hauglund et al. (2015a)
D174 GCA_000422095.1 Hauglund et al. (2015b)
89010807N GCA_000963635.1 Heaton et al. (2015)
USDA-ARS-
SAM-185
GCA_000349785.1 Harhay et al. (2013)
USDA-ARS-
USMARC-183
GCA_000349765.1 Harhay et al. (2013)
USDA-ARS-
USMARC-184
GCA_000819525.1 None
USMARC_2286 GCA_000439735.1 Koren et al. (2013)
36950 GCA_000234745.1 Michael et al. (2011)
3480 GCA_000259545.1 None
ATCC_43137 GCA_000754275.1 Davenport et al. (2014)
HB01 GCA_001663095.1 Peng et al. (2016)
HB03 GCA_000512395.1 None
HN06 GCA_000255915.1 Liu et al. (2012)
OH1907 GCA_000973565.1 None
OH4807 GCA_000973525.1 None
PMTB2.1 GCA_001578435.1 None
Pm-3 GCA_001721885.1 None
Pm70 GCA_000006825.1 May et al. (2001)
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was performed on all M. haemolytica samples. Catalase and motility
were also performed on H. somni isolates.M. bovis samples were con-
firmed as Mycoplasma by colony morphology, Dienes stain, and digi-
tonin susceptibility prior to identification.
Ninety-four isolates of the four target organisms were frozen
at 280. Isolates were preferentially selected from cases rather than
controls, generally from samples withmoderate to large numbers of the
organism in pure or predominant culture, and selection was spread out
over the 6 months of the study. Four nonhemolytic M. haemolytica
isolates were identified and removed from further analysis.Mycoplasma
spp. were picked based on rapid growth and classic appearance for
M. bovis, with only one morphotype present to prevent mixed cultures.
In total, 74 case samples and 20 control samples were submitted for
sequencing:H. somni (n= 16; 13 cases, three controls),M. bovis (n = 20;
17 cases, three controls), M. haemolytica (n = 28; 20 cases, eight
controls), and P. multocida (n = 30; 24 cases, six controls). Species-
identified isolates from dairy cattle were streaked onto various media
and cultured at 37 for 1–5 d, depending on the species (Table 2). A
single colonywas added to 5ml of PPLO broth forM. bovis isolates and
BHI broth for the other three species, and incubated at 37 for 1–5 d
prior to DNA isolation.
Oneswabfromeachof thebeefcattle sampledwasplatedonsheepblood
agar, Columbia agar, and PPLO agar plates, and cultured at 37 for 1–5 d.
Ten single colonies were isolated by morphology, replated, and cultured as
described. A total of 10 samples were submitted from beef feedlot cattle:
M. haemolytica (n = 2; two cases) and P. multocida (n = 8; eight cases).
DNA isolation
A 2.5 ml culture was centrifuged at 13,000 rpm for 5 min forH. somni,
M. haemolytica, and P. multocida, and for 20 min for M. bovis. The
supernatant was discarded and the pellet was resuspended in 200 ml of
PBS. DNA was extracted using the QIAamp Cador Pathogen Mini Kit
(Qiagen Inc., Valencia, CA) according to themanufacturer’s instructions.
PCR identification
PCRwith species-specific primerswas used to identify the four bacterial
species from isolates obtained from beef cattle, and to confirm the
biochemical (aerobic) andmorphologic (Mycoplasma) identification of
the isolates from the dairy cattle. Primers were designed in Primer3
(Koressaar and Remm 2007; Untergrasser et al. 2012) to targeted genes
specific to each species (Table 3). PCR protocols for M. haemolytica
(Alexander et al. 2008) and P. multocida (Ullah et al. 2009) were
performed as described previously. Protocols forH. somni andM. bovis
were developed during this study. PCR was performed on an Eppendorf
Mastercycler (Eppendorf, Hamburg, Germany) with 1· GoTAQ Green
Master Mix (Promega Biosciences LLC, San Luis Obispo, CA), 10mMof
each primer and 10 ng of DNA for 5min at 95, 35 cycles of 30 sec at 95,
30 sec at 56, and 45 sec at 72, followed by 10 min at 72. Products were
visualized on a 1.5% agarose gel using a ChemiDoc-ItTS2 Imager (UVP,
LLC, Upland, CA), purified using the QIAquick PCR Purification Kit
(Qiagen), Sanger sequenced (www.davissequencing.com) and aligned
to their respective reference genomes using Bowtie2–default v2.2.8
(Langmead and Salzberg 2012) to verify that the appropriate target
regions were amplified.
Library construction and sequencing
The PCR-confirmed DNA samples were sonicated on a Diagenode
Bioruptor Pico Ultrasonicator (Diagenode Inc., Denville, NJ) to shear
the DNA into 250 bp fragments. Next-generation sequencing libraries
were created using the Kapa Genomic DNA Library Preparation kit
(Kapa Biosystems, Wilmington, MA). The NEBNext Multiplex Oligos
for Illumina kit (New England BioLabs Inc., Ipswich, MA) was used for
indexing. The samples were sequenced (whole-genome shotgun,
paired-end, 100 bp) on an Illumina HiSeq2500 sequencer at the
Vincent J. Coates Genomics Sequencing Laboratory at UC Berkeley
(supported by NIH S10 Instrumentation grants S10RR029668 and
S10RR027303). A total of 104 isolates were whole-genome se-
quenced, along with five technical replicates.
Read cleanup and de novo assembly
Rawreadswere run through expHTSv0.0.Oct212015 (Street etal.2015),
which screens for contaminants using a mapped based approach,
de-duplicates reads using Super-Deduper v2.0, performs quality trim-
ming using Sickle v1.40, overlaps paired-end reads using Flash2 v2.2.00,
and performs a quality analysis. Cleaned reads were then de novo
assembled using the SPAdes assembler v3.5.0 (Bankevich et al. 2012)
by running through the expHTS pipeline. Contigs were aligned to
GenBank using BLAST (Altschul et al. 1990).
Mapping assembly and genetic diversity
Available reference sequences were obtained fromNCBI for each of the
four species of interest (Table 1). Sequence reads from each isolate were
aligned to their respective reference sequences using Bowtie2–default
v2.2.8. SAM files were converted to BAM files and sorted using SAM-
tools v1.3 (Li et al. 2009). Consensus sequences were called using
ANGSD v0.915 (Korneliussen et al. 2014) using -doFasta 3, which uses
the base with the highest effective depth, and a minimum MAPQ
score = 20. Average coverage for each consensus sequence was deter-
mined using SAMtools Depth v1.3. Consensus sequences were aligned
and genetic distance trees, which were bootstrapped 100 times, were
generated using SeaView v4.6.1 (Gouy et al. 2010).M. haemolytica sam-
ple sequences mapped to reference sequence USA-ARS-USMARC-183
were genotyped using previously described methods (Clawson et al.
2016). Statistical significance of genotype and the probability of being a
case or control was assessed using the Fisher’s exact test.
Antimicrobial resistance
Raw reads and de novo assembled contigs from each sample were
aligned to the Resfinder database (v3-20-2017; Zankari et al. 2012)
using Short Read Sequence Typing for Bacterial Pathogens (SRST2;
Inouye et al. 2014) v0.2.0 and ABRicate v0.5-dev (https://github.com/
tseemann/abricate), respectively, using default settings to identify
n Table 2 Growth conditions for each of the four species used during this study
Species Plate Media Days for Growth Broth Media Days for Growth Shaker Environment
Histophilus somni Columbia agar 1–2 BHI 1–2 N/A Anaerobic
Mycoplasma bovis PPLO 5 PPLO 5 N/A 5% CO2
Mannheimia haemolytica Sheep’s blood agar 1–2 BHI 1–2 250 rpm Facultative
Pasteurella multocida Sheep’s blood agar 1–2 BHI 1–2 250 rpm Facultative
BHI, brain–heart infusion; PPLO, pleuropneumonia-like organism.
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resistance genes. For gene variants that confer resistance, de novo
assembled contigs were aligned to the Comprehensive Antibiotic Resis-
tance Database (CARD; Jia et al. 2017) variant model database using
the BLAST-like alignment tool (BLAT; Kent 2002) v35, and visually
inspected for resistance-conferring SNPs. Raw reads from each sample
were aligned to the PlasmidFinder database (v3-23-2017; Carattolli et al.
2014) using the SRST2 v0.2.0 using default settings. The NCBI reference
sequences were aligned to the Resfinder database using ABRicate.
Susceptibility testing
Microdilution susceptibility testing of isolates was performed at the
Kansas State Veterinary Diagnostic Laboratory using the Sensititre
bovine/porcine plate (Thermo Scientific; plate code BOPO6F, Supple-
mental Material, Table S1), which tests for susceptibility to 18 drugs
across nine antimicrobial classes: (i) b-lactam [Ampicillin (AMP),
Ceftiofur (CEFT), Penicillin (PEN)]; (ii) tetracycline [Chlortetracycline
(CHLOR), Oxytetracycline (OXY)]; (iii) fluoroquinolone [Danofloxacin
(DAN), Enrofloxacin (ENRO)]; (iv) phenicol [Florfenicol (FLOR)]; (v)
aminoglycoside [Gentamicin (GEN), Neomycin (NEO), Spectinomycin
(SPEC)]; (vi) sulfonamide [Sulfadimethoxine (SUL)]; (vii) trimethoprim/
sulfonamide [Trimethoprim-Sulfamethoxazole (TMS)]; (viii) macrolides-
lincosamides (MLS) [Clindamycin (CLIN), Tilmicosin (TIL),
Tulathromycin (TUL) Tylosin tartrate (TYL)]; and (ix) pleuromutilans
[Tiamulin (TIA)] (Table 4). Breakpoints were chosen based on cattle-
specific Clinical and Laboratory Standards Institute (CLSI) guidelines
(CLSI 2013) when possible. CLSI swine-specific breakpoints were used
for AMP and TIA, canine-specific breakpoints for CLIN and canine-
and equine-specific breakpoints for GEN, and human-specific break-
points for SUL and TMS. The CLSI breakpoints were not available
for NEO and TYL, and therefore human-specific breakpoints from
the National Antimicrobial Resistance Monitoring System were used
(Table 4; FDA 2013). Wherever possible, breakpoints for the actual
pathogens tested in this study were utilized. Based on these break-
points, isolates were classified as susceptible, intermediate, or resistant.
For analysis purposes, susceptible and intermediate isolates were con-
sidered to be susceptible. Crude prevalence of phenotypic resistance for
each drug tested was calculated by bacterial species and across all three
species. In addition, prevalence of multidrug resistant (MDR) pheno-
types (defined as resistance to more than two antimicrobial drug clas-
ses) was calculated and MDR patterns were assessed.
In order to compare phenotypic and genotypic susceptibility results,
identifiedresistancegenesweremappedtotheantimicrobialdrugclasses
to which they are known to confer resistance (Table 4). Proportion of
isolates with concordant and discordant genotype–phenotype results
were calculated for each antimicrobial drug and organism.
Statistical significance of discordance was assessed using the mid-P
exact for binomial paired data with a two-tailed P-value (Edwards
1948), unless there were at least 20 discordant observations or the
marginal counts were equal to zero, in which case McNemar’s test with
continuity correction was used (Fagerland et al. 2013). If there was a
lack of observations in any of the genotype–phenotype concordance–
discordance combinations, 0.5 was added to the count in order to
enable calculation of the test statistic. OpenEpi was used for all
calculations (Dean et al. 2013). A two-tailed P-value was used and
the a level was 0.05.
Data availability
Sequence reads are available in the NCBI Sequence Read Archive as
Bioproject PRJNA306895 and SRA accession number SRP095705. De
novo assemblies are available as NCBI whole genome shotgun se-
quences (accession numbers: LQCX01-LQGS01). GenBank accession
numbers are SRR5133037–SRR5133136. Additional supporting data
are provided in Figure S1, Figure S2, Figure S3, Figure S4, Figure S5,
Figure S6, File S1, Table S1, Table S2, Table S3, Table S4, and Table S5.
RESULTS
Sequencing and assembly
Laboratory-confirmed isolates of H. somni (n = 16; 13 cases, three
controls), M. bovis (n = 20; 17 cases, three controls), M. haemolytica
(n = 28; 20 cases, eight controls), and P. multocida (n = 30; 24 cases, six
controls) from dairy cattle; and M. haemolytica (n = 2; two cases)
and P. multocida (n = 8; eight cases) from beef cattle were se-
quenced, and raw reads were processed and assembled (Table 5
and Table S2). Staphylococcus aureus contamination was identified
in one of the P. multocida samples isolated from an affected dairy
calf and from two of the beef cattle samples, as well as in one of the
beef cattle M. haemolytica samples. These samples were excluded
from further analysis. A total of 100 sequences—16 H. somni (all
dairy), 20 M. bovis (all dairy), 29 M. haemolytica (28 dairy, one beef),
and 35 P. multocida (29 dairy, six beef)—were selected for further
analysis. Raw reads from these 100 samples were mapped to each
of their respective reference sequences and subjected to further analysis.
Of the 29 M. haemolytica samples, 22 were classified as genotype
2 and the other sevenwere classified as genotype 1, as recently described
by Clawson et al. (2016). Of the 22 samples classified as genotype 2,
19 were obtained from cases (86.4%; P , 0.01); while of the seven
samples classified as genotype 1, five were obtained from controls
(71.4%; P , 0.01). Samples classified as genotype 2 have largely been
associated with those taken from BRD-affected animals, while samples
classified as genotype 1 have been associated with nonclinical isolates of
M. haemolytica. There have been some genotype 1 samples obtained
from BRD-affected animals, as well as genotype 2 samples obtained
from non-BRD–affected animals (Clawson et al. 2016).
n Table 3 Primers and PCR amplification protocols used in this study
Species Primer Sequence (59-39) Tm ()
Histophilus somni Lob1F AAATGGAAACACCCAACCAA 56.3
Lob1R CAAACGCTTGATACGCTCA 58.4
Mycoplasma bovis MB528F CATGCGAAAACACTGCAACT 58.4
MB528R CCACGCATTCAGAATTGAAA 56.3
Mannheimia haemolytica [Alexander et al. 2008] LktF GCAGGAGGTGATTATTAAAGTGG 61
LktR CAGCAGTTATTGTCATACCTGAAC 61.2
Pasteurella multocida [Ulhah et al. 2009] KMT1SPG GCTGTAAACGAACTCGCCAC 62.4
KMT1T7 ATCCGCTATTTACCCAGTGG 60.4
Positive control 16SF GCTAACTCCGTGCCAGCAG 64.5
16SR CGTGGACTACCAGGGTATCTAATC 65.6
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Genetic distance trees were generated to visualize the genetic distance
between the genomic sequences and mapped assemblies. Overall, the
sequence assemblies for the samples collected in this study increased the
genetic diversity for available WGS for three out of the four species
analyzed, H. somni, M. bovis, and P. multocida (Figure 1). Five of
the H. somni samples contained sequences that were genomically
distant from both available reference sequences, while the other
11 samples were genomically distant from reference sequence
129PT (Figure S1a). While the M. bovis samples showed little
variation among themselves, all 20 samples were genomically distant
from the five reference sequences (Figure S1b). The M. haemolytica
sample population was the only species that revealed little genetic
variation between the samples collected and the available reference
sequences (Figure S1c). The seven samples classified as genotype
1 clustered together away from the other 22 samples (Figure S1c).
The P. multocida sample population showed significant variation
between the samples collected and six of the 11 available reference
sequences (Figure S1d). For samples aligned to P. multocida ref-
erence sequences 3480, HN06, OH1905, OH4807, PMTB2.1, and
Pm70, the study samples clustered together away from the refer-
ence sequence, showing a large distance between the sample group
and the reference sequences. For the remaining five reference se-
quences, 36950, ATCC_43137, HB01, HB03, and Pm-3, there was
little genetic diversity between the samples collected and the ref-
erence sequences.
ARGs
Raw read and de novo assembled contigs were aligned to the Resfinder
database using SRST2 and ABRicate, respectively. Table 4 lists known
ARG detected and the antimicrobial(s) to which the genes can confer
resistance. Phenotypic antimicrobial susceptibility testing results were
obtained for 64 isolates (13 H. somni, 26 M. haemolytica, and 25
P. multocida) for 18 antimicrobials from nine classes. The remaining
three samples ofH. somni, three samples ofM. haemolytica and 10 sam-
ples of P. multocida failed to grow in the susceptibility testing positive
control media and were excluded from analysis. Using in silico ARG
prediction methods, 11 total ARG were detected, with two genes spe-
cific to H. somni isolates (ermF and dfrA14), two genes specific to
M. haemolytica isolates (ROB-1 and cat2), and the other seven detected
inH. somni,M. haemolytica, and P.multocida (Figure 2). NoARGwere
detected in any of the M. bovis samples, and therefore, these samples
were not subjected to susceptibility testing. Raw reads were mapped to
the PlasmidFinder database using SRST2 to determine whether ARG
present were on plasmids or integrated into the genome. No plas-
mids containing known ARG sequences were detected using this
method. Additionally, alignment of de novo assembled contigs to
the CARD protein variant model database did not reveal any vari-
ants in genes known to confer resistance to antimicrobials.
H. somni ARG: In silicoARG identification was performed for the two
H. somni reference sequences 2336 and 129PT (Figure 2). No ARG
n Table 4 Mapping of identified resistance genes to antimicrobial drugs included on the broth microdilution phenotypic susceptibility
panel
Resistance Gene Antibiotic (Abbreviation)
Antibiotic
Class
CLSI
Approved
Breakpoint
Breakpoint (mg/ml)
Susceptible Intermediate Resistant
tetH Chlortetracycline (CHLOR) Tetracycline Yes #2 4 $8
Oxytetracycline (OXY) Tetracycline Yes #2 4 $8
aph3-Ia Neomycin (NEO) Aminoglycoside Noa #2 4 $8
strA None tested N/A N/A N/A N/A N/A
strB None tested N/A N/A N/A N/A N/A
ROB-1 Ampicillin (AMP) b-Lactam Yesb #0.5 1 $2
Ceftiofur (CEFT) b-Lactam Yes #2 4 $8
Penicillin (PEN) b-Lactam Yes #0.25 0.5 $1
sul2 Sulfadimethoxine (SUL) Sulfonamide Yesc #256 — $512
Trimethoprim-sulfamethoxazole (TMS) Sulfonamide Yesd ,0.5 and 9.5 1–2 and 19–38 4 and 76
erm42/ermF Clindamycin (CLIN) MLS Yese #0.5 1 - 2 $4
Tilmicosin (TIL) MLS Yesf #8 16 $32
Tulathromycin (TUL) MLS Yes #16 32 $64
Tylosin tartrate (TYL) MLS Nog #8 16 $32
cat2 Florfenicol (FLOR) Phenicol Yes #2 4 $8
floR Florfenicol (FLOR) Phenicol Yes #2 4 $8
dfrA14 Trimethoprim-sulfamethoxazole (TMS) TMS Yesd ,0.5 and 9.5 1–2 and 19–38 4 and 76
None identified Danofloxacin (DAN) Fluoroquinolone Yesc #0.25 — —
None identified Enrofloxacin (ENRO) Fluoroquinolone Yes #0.25 0.5–1 $2
None identified Gentamicin (GENT) Aminoglycoside Yesh #2 4 $8
None identified Spectinomycin (SPEC) Aminoglycoside Yes #32 64 $128
None identified Tiamulin (TIA) Pleuromutilin Yesi #16 — $32
MLS, macrolide-lincosamide-streptogramin.
a
For Neomycin, we used NARMS 2011 breakpoints for aminoglyosides.
b
For Ampicillin, we used CLSI breakpoints for swine that were validated for the following bacteria: Actinobacillus pleuropneumoniae and P. multocida.
c
For Danofloxacin, we used CLSI breakpoints for cattle, but only validated for the following bacteria: M. haemolytica and P. multocida.
d
For Sulfadimethoxine and TMS, we used CLSI breakpoints for humans with systemic disease and validated in Enterobacteriaceae.
e
For Clindamycin, we used CLSI breakpoints for canines that were validated for the following bacteria: Staphylcoccus spp. and b-hemolytic Streptococci.
f
For Tilmicosin, we used CLSI breakpoints for cattle, but only validated for the following bacteria: M. haemolytica.
g
For Tylosin, we used the same breakpoints as in the following document: https://www.ars.usda.gov/SP2UserFiles/Place/60400520/NARMS/ABXEntero.pdf.
h
For Gentamicin, we used canine and equine breakpoints validated in Pseudomonas aeruginosa and Enterobacteriaceae and the equine breakpoint for Actinobacillus spp.
i
For Tiamulin, we used CLSI breakpoints for swine that were validated for the following bacteria: Actinobacillus pleuropneumoniae.
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were predicted in reference sequence 129PT and only tetH was pre-
dicted in reference sequence 2336. Nine ARG were detected in the
H. somni isolates (Figure S2). Two aminoglycoside resistance genes that
confer resistance to the drugs KAN andNEO (aph3-Ia) and streptomycin
(strA, strB) were detected. Two macrolide-lincosamide-streptogramin B
(MLSb) resistance genes (erm42 and ermF) were also detected, as
was a phenicol resistance gene (floR), a sulfonamide resistance gene
(sul2), a trimethoprim resistance gene (dfrA14), and a tetracycline
resistance gene (tetH) (Figure 2). There was a 79.2% concordance
rate between genes identified using raw reads and de novo assembled
contigs.
M. haemolytica ARG: Different ARG were identified across M. hae-
molytica reference sequences. The genes aph3-Ia, strB, sul2, tetH and
the b-lactamase gene, ROB-1, were detected in reference sequence
M42548; ROB-1 was detected in reference sequence 89010807N_lktA;
tetHwas detected in reference sequence 89010807N_lktA and reference
sequence 89010807N; no ARG were detected in any of the other avail-
able reference sequences (n = 7, Figure 2). Seven of the eight ARG
detected in M. haemolytica isolates (aph3-Ia, erm42, floR, strA, strB,
sul2, and tetH) were also found inH. somni and P.multocida (Figure 2).
No ARG were detected in the only M. haemolytica sample sequenced
fromBRD-affected beef cattle (Figure S3). Two of the genes (erm42 and
floR) were not detected in any reference sequence but have been
previously reported (Clawson et al. 2016). There was an 89.3% con-
cordance rate between genes identified using raw reads and de novo
assembled contigs. There was complete linkage of ARG aph3-Ia,
strA and strB in 28 out of 29 samples, showing homology to the
conserved backbone of ICEMh1 and ICEPmu1 (Figure S3). The
presence of the conserved ICE backbone has been associated with
samples classified as genotype 2. Here, 21 out of 22 samples classified
as genotype 2 contained regions homologous to the ICE backbone
and all seven samples classified as genotype 1 also contained regions
homologous to the ICE backbone. Additionally, the phenicol resis-
tance gene cat2 was identified in six out of 29 samples. Six of the
seven samples classified as genotype 1 contained the cat2 ARG,
while the other 22 samples, classified as genotype 2, did not contain
the cat2 ARG (Figure S3).
P. multocida ARG: The availableP.multocida reference sequences had
similar ARG variation to that seen in the M. haemolytica reference
sequences. All seven of the ARG (tetH, aph3-Ia, erm42, strA, strB, floR,
and sul2) detected in the P. multocida samples were also detected in
reference sequence 36950 (Michael et al. 2011). The gene tetB was
detected in reference sequence HB01, but no ARG were detected in
any of the other nine reference sequences (Figure 2). Seven of the
11 ARG were detected in the P. multocida samples originating from
dairy cattle (Figure 2). Sequences from two samples obtained from beef
cattle contained four and five of seven ARG, tetH, aph3-Ia, strA, strB
and tetH, aph3-Ia, erm42, strA, strB, respectively, but there were no
ARG detected in the other four samples obtained from beef cattle
(Figure S4). One of the 35 samples contained the b-lactamase gene,
ROB-1. There was a 76.5% concordance rate between genes identified
using raw reads and de novo assembled contigs. Like M. haemolytica
samples, there was complete linkage of ARG aph3-Ia, strA and strB in
31 out of 35 samples, showing homology to the conserved backbone of
ICEMh1 and ICEPmu1.
Phenotypic susceptibility testing results
All 64 isolates displayed phenotypic resistance toNEO at a resistant
breakpoint of $32 mg/ml (File S1 and Table 6). All 25 of the
P. multocida isolates were also resistant to TYL, OXY, SUL, and
CLIN, while all 26 of the M. haemolytica were resistant to OXY
(Figure 3). None of the isolates displayed phenotypic resistance to
SPEC or ENRO, and a single H. somni isolate was resistant to CEFT
(Table 6 and Table S3). M. haemolytica was the only organism that
displayed resistance to TUL (five out of 26 isolates). None of the
isolates from any species were susceptible to all drugs tested; 61 were
MDR (defined as exhibiting phenotypic resistance to more than two
antimicrobial classes tested) and the remaining three were resistant
to only two classes of antimicrobials (Figure S5).
Genotype–phenotype concordance
Concordance rates for antimicrobial resistance genotype andphenotype
varied widely for each antimicrobial drug (Table 6). Across all three
organisms, ENRO and NEO exhibited 100% concordance, with all
isolates displaying phenotypic susceptibility and none containing
genes typically associated with resistance to these antimicrobials,
i.e., adenylyltransferases AAD(3$) and AAD(9) for SPEC and parC,
parE, gyrA, and gyrB for ENRO. As with NEO, SPEC also exhibited
high genotype–phenotype concordance (98%), but in contrast with
NEO, this concordance was driven by presence of aph3-Ia and cor-
responding phenotypic resistance. Concordance to OXY was also
very high across all three organisms; of the 64 isolates tested, 62 dis-
played phenotypic resistance to OXY and contained the tetH re-
sistance gene. All three organisms exhibited statistically significant
phenotype–genotype discordance for CHLOR and TIL (P , 0.05;
Table S3, Table S4, and Table S5). CHLOR discordance was driven
by phenotypic susceptibility in the presence of tetH (opposite the
results for OXY). For H. somni and P. multocida, TIL discordance
resulted from phenotypic susceptibility in the presence of ermF and/
or erm42. Interestingly, erm42 has previously been identified in
MDR P. multocida isolates from cases of BRD, but has yet to be
described in H. somni (Kadlec et al. 2011). Unlike TIL discordance
in H. somni and P. multocida, discordance in M. haemolytica was
due largely to phenotypic resistance without identification of a
known macrolide resistance gene.
H. somni andM. haemolytica demonstrated significant discordance
for CLIN, however this discordance was driven by different dynamics
(Table S3 and Table S4). Within H. somni, discordance resulted from
phenotypic susceptibility in the presence of both erm42 and ermF,
n Table 5 Average assembly statistics for each species sequenced in this study from de novo assembled contigs
Species Contig Coverage Total Length N50 Min. Contig Max. Contig
Histophilus somni 77 62.46 2,136,280 89,438 1094 294,083
Mycoplasma bovis 74 72.41 943,236 27,508 1061 59,658
Mannheimia haemolytica 105 35.68 2,637,528 70,779 1068 282,147
Pasteurella multocida 33 29.33 2,317,940 171,866 1099 469,530
Total length is the total of all contig lengths; N50 is 50% of the mass of distribution of the contig lengths; Min. contig and Max. contig are the length of the shortest
and longest contigs in each assembly.
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whereas phenotypic resistance and a lack of any known macrolide re-
sistance genes drove the discordance in M. haemolytica.
H. somni and P. multocida exhibited significant discordance for
FLOR, which in both organisms resulted from phenotypic susceptibil-
ity despite presence of the floR resistance gene. In addition, TUL was
significantly discordant in both H. somni and P. multocida (P , 0.05;
Table S3, Table S4, and Table S5), in both cases due to presence of
erm42 and/or ermF without corresponding phenotypic resistance.
Phenotypeandgenotype results forDANandTMSwere significantly
discordant in bothM. haemolytica and P.multocida (P, 0.05; Table S4
and Table S5). For DAN, this discordance was due to phenotypic re-
sistance without identification of a known danofloxacin resistance gene.
Conversely, TMS discordance was driven by phenotypic susceptibility
despite presence of the sul2 gene.
In addition, H. somni exhibited significant discordance for GENT,
with 10 out of 13 isolates displaying phenotypic resistance but none
containing a resistance gene known to confer resistance to this drug.
All 10 of these isolates contained aph3-Ia, but this gene is typically
associated with resistance to the aminoglycosides kanamycin, NEO,
and paromomycin within Enterobacteriaceae spp. (Livermore et al.
2001). The breakpoint used for GENTwas developed for Pseudomonas
aeruginosa and Enterobacteriaceae in canines and equids, and
Actinobacillus spp. in equids (CLSI 2013), and it is unknown whether
these breakpoints are appropriate for H. somni in cattle.
M. haemolytica isolates also displayed statistically significant discor-
dance for both CEFT and TYL (P, 0.05; Table S4). In the case of TYL,
25 of the 26 isolates were phenotypically resistant, but only six of these
25 isolates contained erm42. CEFT discordance resulted from the fact
that none of the isolates whose genomes contained ROB-1 experienced
CEFT resistance due to the presence of this b-lactamase gene.
P. multocida isolates were also significantly discordant for the pleu-
romutilin TIA (P, 0.05; Table S5), with 21 out of 25 isolates displaying
Figure 1 Genetic distance trees from mapped assemblies of the four bacterial species, Histophilus somni aligned to reference sequence 2336,
Mycoplasma bovis aligned to Hubei1, Mannheimia haemolytica aligned to reference sequence M42548, and Pasteurella multocida aligned to
reference sequence 36950. Red circle, beef cattle; blue box, reference sequence; green box, M. haemolytica genotype 1 (Clawson et al. 2016).
Scale bar represents number of substitutions per site.
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phenotypic resistance despite lack of an identified pleuromutilin re-
sistance gene within the isolates’ genomes.
Macrolide resistance is of particular concern, as BRD is typically treated
with either tetracyclines or macrolides. We identified two MLSb resistance
genes within the 64 samples, erm42 and ermF. The genotype–phenotype
concordance results differed greatly by the combination of gene, bacteria,
and macrolide drug in question, as illustrated in Figure 4. When averaged
across all three bacterial species, the genotype–phenotype discordance rates
were statistically significant for all four macrolides tested (Table 6). How-
ever, discordance rates and significance varied by organism (Table S3,
Table S4, and Table S5). Additionally, there was not a strong correlation
between the number of ARG detected in each sample and the number of
antimicrobials that each sample was resistant to (Figure S6).
DISCUSSION
Genome assembly and diversity
Additional WGS from BRD pathogens are needed to help understand
genetic diversity and its role in pathogenesis, genotype–phenotype asso-
ciations, and the relationship between genomic features and clinical dis-
ease. This study doubled the number of available genomic sequences for
these four species. In addition to expanding current WGS databases,
standardization of genome analysis methods for genomic epidemiological
interpretation is important (Gilmour et al. 2013). Aswe have shown in this
study, results obtained from de novo assemblies vs. consensus sequences
constructed from mapping to reference genomes can be highly variable.
This is demonstrated not only by the differences in genetic distances for
each consensus sequence calledwhenmapped to their respective reference
sequences (Figure S1), but also by variability in ARG (Figure 2). However,
there are many benefits to using a reference-based mapping approach,
particularly whenmany samples need to be sequenced and analyzed. One
such advantage is the computing power needed for consensus mapping is
much lower as compared to de novo assembly and phylogenomic analyses
using mapped assemblies yield similar results to those produced by de
novo assemblies (Fitz-Gibbon et al. 2017). Genome assembly via mapping
of reads to reference sequences enabled us to efficiently characterize var-
iation within our study population, even if there is a slight bias toward the
reference sequences (Figure S1).
Little variation was detected between samplesmapped to each of the
10M. haemolytica reference sequences. This is likely due to similarity in
strains from cattle across the Midwest and California, as nine of the
10 reference sequences were obtained from cattle in the Midwest. Sim-
ilarly, P. multocida samples clustered much more closely to reference
sequences 3480, HN06, OH1905, OH4807, PMTB2.1, and Pm70, as
each of these samples were obtained from cattle in California or the
Midwest. In contrast, P. multocida samples in our study clusteredmore
distantly from reference sequences 36950, ATCC_43137, HB01, HB03,
and Pm-3, which were obtained from cattle in Germany or China. In
this dataset, there was a clear distinction between P. multocida isolates
collected from the beef and dairy cattle populations with the exception
of one sample. However, it is important to note that only six of the
35 P. multocida samples analyzed were obtained from BRD-affected
beef cattle. Further investigations with larger sample sizes from broader
geographical ranges will be required to validate these observations.
Predicting antimicrobial resistance
The ability to predict ARG in silico would have a significant impact on
our ability to diagnose and treat pathogenic diseases and monitor the
Figure 2 Prevalence of resistance genes among isolates of Histophilus somni (N = 16), Mannheimia haemolytica (N = 29), and Pasteurella
multocida (N = 35), as well as available reference sequences. +, present; 2, absent.
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spread of ARG (Koser et al. 2014). In a study of animals previously
treated with antimicrobials, resistance was identified in 72% of
M. haemolytica and 50% of P. multocida isolates, with 13 ARG present
in H. somni (Klima et al. 2014). Other studies in healthy cattle suggest
that the prevalence of antimicrobial resistance in BRD-associated bac-
teria may be relatively low (Noyes et al. 2015).M. haemolytica and
P. multocida harbor integrative and conjugative elements that enable
the transfer of gene blocks between the species (Klima et al. 2014) and
confer resistance to antimicrobials (Michael et al. 2011; Eidam et al.
2015).M. bovis lacks a cell wall and is resistant to drugs that target the
cell wall of Gram-negative bacteria; to date no ARG have been found in
any strain of M. bovis (Maunsell et al. 2011).
In this study, we detected 11 antibiotic resistance genes within the
sample population, including three aminoglycoside resistance genes, two
macrolide-lincosamide-streptogramin resistance genes, two phenicol and
one each of b-lactam, sulfonamide, fluoroquinolone, tetracycline, and
trimethoprim resistance genes. Tetracyclines and macrolides are often
used as first-line agents in the treatment of BRD. The prevalence of tetH
and erm42 were relatively high in this population, and the presence of
these ARG within BRD-associated bacterial isolates could render BRD
treatmentmore challenging (Livermore et al. 2001). However, prevalence
of resistance to antimicrobials typically used as second- or third-line
treatments was relatively low, i.e., floR and cat2 for florfenicol. As a result,
several alternative, commonly used antimicrobials for BRD treatment
(USDA 2011b) could still be effective based on our findings.
Phenotypic antimicrobial resistance and the presence of ARG have
both beendemonstrated forH. somni,M.haemolytica, andP.multocida
(Klima et al. 2014; DeDonder and Apley 2015). It is known that anti-
microbials that target the cell wall, such as b-lactams, are not effective
againstM. bovis due to the lack of a cell wall. While we did not identify
ARG in any of the M. bovis genomes in this study, phenotypic resis-
tance within this organism has previously been demonstrated (Kawai
et al. 2014; Kong et al. 2015). Each of the other three species has shown
resistance to tetracyclines (Kehrenberg et al. 2001; D’Amours et al.
2011), which is the primary resistance gene found inH. somni samples
in previous studies, but the majority of resistance genes previously
found have been in P. multocida and M. haemolytica.
Previous studies have shownmacrolide-lincosamide-streptogramin,
kanamycin, NEO, and streptomycin resistance in H. somni samples
(DeDonder and Apley 2015), but there were no ARG found inH. somni
reference sequences other than tetH. However, recent studies have
shown the presence of seven out of nine ARG found inH. somni samples
during this study (Klima et al. 2014), showing the variation of ARG
found in different strains. Recent studies showing the presence of known
ARG, as well as phenotypic antimicrobial resistance, have primarily been
done in diseased animals from feedlots around the Midwest, while the
reference sequence samples were obtained from diseased animals in
California. Our study shows a similarity in ARG to the recent study of
samples obtained from feedlots in Texas, Nebraska, and Alberta, Canada
(Klima et al. 2014). Importantly, eight of nine ARG found in H. somni
and three of eight ARG found inM. haemolytica were not found in any
of the previously available reference genome sequences.
It is important to note that there was slightly more ARG detected in
each sample using raw reads compared to ARG detected using de novo
assembled contigs. Using raw reads for gene detection has been shown
to be superior to assembly-based approaches. This is primarily because
assembly-based approaches are dependent on the quality of the sequenc-
ing, the assembly method used, and the quality of the assembly itself
(Clausen et al. 2016).
The grouping of ARG within each sample is not surprising, as these
genes would likely increase the survival rate of the bacteria, thus
representing a substantial fitness benefit and eventually becoming
fixed in the population (Griffin et al. 2010). The fact that three out of
four species of bacteria associated with BRD share many of the same
ARG is likewise unsurprising, as infection is highly associated with
the presence of multiple pathogens (Griffin et al. 2010). Additionally,
previous studies have shown there is a high incidence of horizontal
gene transfer of ARG-containing plasmids between M. haemolytica
and P. multocida (Klima et al. 2014), and the presence of the integra-
tive and conjugative elements found in these two species have been
associated with isolates recovered from BRD-affected cattle (Neibergs
et al. 2014). Here, we show that 97% of M. haemolytica samples and
86% P. multocida samples obtained from BRD-affected cattle contain
regions homologous to the ICE backbone. It was interesting that no
n Table 6 Concordance of phenotypic and susceptibility results for all three organisms (64 isolates)
Pheno: S Pheno: R
Class Antibiotic Geno:R Geno:S Geno:R Geno:S Discordant (%) Concordant (%) P-Value
b-Lactam Ampicillin 4 42 15 3 11 89 0.73
b-Lactam Ceftiofur 19 44 0 1 31 69 ,0.001
b-Lactam Penicillin 4 41 15 4 13 88 0.99
Tetracycline Chlortetracycline 53 1 10 0 83 17 ,0.001
Tetracycline Oxytetracycline 1 1 62 0 2 98 0.50
Fluoroquinolone Danofloxacin 0 44 0 20 31 69 ,0.001
Fluoroquinolone Enrofloxacin 0 64 0 0 0 100 0.32
Phenicol Florfenicol 24 26 14 0 38 63 ,0.001
Aminoglycoside Gentamicin 0 52 0 12 19 81 0.002
Aminoglycoside Neomycin 0 0 63 1 2 98 1.0
Aminoglycoside Spectinomycin 0 64 0 0 0 100 0.37
Sulfonamide Sulfadimethoxine 1 1 60 2 5 95 0.63
Trimeth/Sulf TMS 33 21 7 3 56 44 ,0.001
Pleuromutilin Tiamulin 0 40 0 24 37 63 ,0.001
MLS Clindamycin 7 6 31 20 42 58 0.02
MLS Tilmicosin 13 21 25 5 28 72 0.06
MLS Tulathromycin 33 26 7 3 52 48 ,0.001
MLS Tylosin tartrate 5 4 33 22 42 58 ,0.001
Pheno, phenotype; S, susceptible; R, resistant; Geno, genotype; Trimeth/Sulf, trimethoprim/sulfonamide; TMS, trimethoprim-sulfamethoxazole; MLS, macrolide-
lincosamide-streptogramin.
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ARG were detected in five of the seven samples collected from un-
treated beef cattle, other than the two P. multocida samples. While
both M. haemolytica and P. multocida are known to exist commen-
sally in the respiratory tract of animals not affected by BRD (Neibergs
et al. 2014), the significance of these findings needs to be substantiated
by a larger number of more diverse samples.
While in silico analysis can be used to identify ARG within WGS
data, it does not reveal the functionality or effectiveness of the ARG
in vivo. Therefore, antimicrobial susceptibility testing should be per-
formed alongside in silico methods in order to understand the expres-
sion of these ARG, at least within laboratory testing conditions. In
addition, extensive metadata should be collected for each sample, in-
cluding the eventual clinical outcome for the animal from which the
sample was taken. These types of data would help us to understand how
knowledge of the presence of ARG within a given genome could po-
tentially predict treatment and morbidity/mortality outcomes.
Genotype–phenotype concordance
The genotype–phenotype results from this study demonstrate the high
degree of variability in concordance rates between different drugs,
genes, and organisms. The ability of antimicrobial resistance genotype
to predict phenotypic susceptibility has been under much discussion
recently, particularly in the context of increased use of WGS as part of
national food safetymonitoring systems (Allard et al. 2016; Burrell et al.
2016). Some of the discordance rates presented in this study were
higher than rates previously reported (Card et al. 2013; Agyekum
et al. 2016). However, the available literature does not include results
for the three organisms included in this study, which suggests that
genotype–phenotype concordance rates may be highly species-specific.
Alternatively, the breakpoints that we utilized for this study may not
have been appropriate for H. somni,M. haemolytica, and P. multocida,
especially since many of the breakpoints were not formulated for
the relevant drug-bacterium-host combinations (Table 4). It has been
shown that when changing the specific parameters of drug-bacterium-
host, the CLSI-approved breakpoints become invalid and in cases were
phenotypic resistance was seen, but no known ARG was detected, it
becomes difficult to discern actual phenotypic resistance from inappro-
priate reporting (DeDonder and Apley 2015). However, even among
breakpoints that were relevant, we found varying levels of genotype–
phenotype concordance. Host- and organism-appropriate breakpoints
were used for ENRO, TUL, FLOR, CHLOR, OXY, CEFT, and SPEC.
While concordance rates were.98% for ENRO,OXY, and SPEC, there
Figure 4 Heatmap showing concordance (blue)
and discordance (red) between erm42 and ermF
presence (black) or absence (gray) and phenotypic
resistance to the four macrolide drugs included in
the susceptibility testing panel (columns), by iso-
late (rows) within organism. CLIN, clindamycin;
TIL, tilmicosin; TUL, tulathromycin; TYL, tylosin
tartrate.
Figure 3 Prevalence of phenotypic resistance to
all drugs tested among isolates of Histophilus
somni (N = 13), Mannheimia haemolytica (N =
26), and Pasteurella multocida (N = 25).
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was significant discordance for CEFT, CHLOR, FLOR, and TUL (P ,
0.05; Table 6). Therefore, issues concerning breakpoints do not fully
account for the relatively high rates of genotype–phenotype discor-
dance observed.
In many cases, the presence of a resistance gene correlated well with
certain drugs within the relevant antimicrobial class, but not others. For
instance, withinM. haemolytica isolates the presence of the ROB-1 gene
correlated well with phenotypic resistance to AMP and PEN, but not
CEFT, to which there was no phenotypic resistance. Therefore, these
results suggest that ROB-1may not cause resistance to third-generation
cephalosporins in M. haemolytica; a similar finding has been demon-
strated with ROB-1 in Canadian Haemophilus influenzae human iso-
lates (Karlowsky et al. 2000). Phenotypic NEO resistance was present
across all 64 isolates, and 63 of the isolates also contained aph3-Ia,
suggesting that this gene may be a very good predictor of neomycin
resistance in H. somni, M. haemolytica, and P. multocida.
Resistance to TYL was nearly 100% within M. haemolytica and
P. multocida isolates. However, presence of the erm42 gene was only
predictive of resistance in P. multocida (Figure 4). Therefore, additional
unrecognized mechanisms or genes are likely responsible for resistance
in the other two species, although inappropriate breakpoints cannot be
discounted. In contrast, the presence of erm42 predicted TUL resistance
well within M. haemolytica, in that all five resistant isolates contained
erm42 and none of the susceptible isolates did. However, the presence
of erm42 in all 25 P. multocida isolates did not result in TUL resistance
(Figure 4). These results highlight the importance of considering
the specific antimicrobial drug, resistance gene, organism, and host
when investigating the ability of genotype to predict phenotype (or
vice versa).
Results of our study demonstrate the complexity of genome-wide
dynamics inmediation of resistance, and emphasize the fact that simple
presence/absence of individual genes does not always predict the
behavior of a given organism under varying levels of antimicrobial drug
exposures. More research is needed to develop reliable and accurate
genomic predictors of antimicrobial resistance, and this research will
likely need to be targeted toward specific drug-bacterium-host combi-
nations. Until such genomic predictors are identified and refined, the
scientific,medical, public health, and regulatory communities should be
cognizantof thepotential limitationsof relyingsolely ongenomicdata to
guide treatment and programmatic or regulatory decisions. Such a
conservative approach is especially relevant to the veterinary commu-
nity, whereWGS of pathogens with high animal health importance has
been limited.
The sequences produced as part of this work represent a first step
toward increased understanding of genome-mediated antimicrobial
resistance dynamics within these important cattle pathogens. However,
the variability in our results highlights the continuing criticality of
collecting pertinent host, production, and health outcome informa-
tion (i.e., metadata) for each isolate. Without such information,
the scientific community will be unable to evaluate the implications
of positive identification of resistance genes within WGS data, and
improve BRD morbidity/mortality outcomes by predicting the most
effective treatment regime for BRDbased on the specific gene-bacterium-
host combination.
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